These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 6319389

  • 1. Defective hepatic lipoprotein receptor binding of beta-very low density lipoproteins from type III hyperlipoproteinemic patients. Importance of apolipoprotein E.
    Hui DY, Innerarity TL, Mahley RW.
    J Biol Chem; 1984 Jan 25; 259(2):860-9. PubMed ID: 6319389
    [Abstract] [Full Text] [Related]

  • 2. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
    Hui DY, Innerarity TL, Milne RW, Marcel YL, Mahley RW.
    J Biol Chem; 1984 Dec 25; 259(24):15060-8. PubMed ID: 6096356
    [Abstract] [Full Text] [Related]

  • 3. Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia.
    Ehnholm C, Mahley RW, Chappell DA, Weisgraber KH, Ludwig E, Witztum JL.
    Proc Natl Acad Sci U S A; 1984 Sep 25; 81(17):5566-70. PubMed ID: 6591204
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.
    Hui DY, Innerarity TL, Mahley RW.
    J Biol Chem; 1981 Jun 10; 256(11):5646-55. PubMed ID: 6263887
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identical structural and receptor binding defects in apolipoprotein E2 in hypo-, normo-, and hypercholesterolemic dysbetalipoproteinemia.
    Rall SC, Weisgraber KH, Innerarity TL, Mahley RW.
    J Clin Invest; 1983 Apr 10; 71(4):1023-31. PubMed ID: 6300187
    [Abstract] [Full Text] [Related]

  • 9. Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids.
    Angelin B, Raviola CA, Innerarity TL, Mahley RW.
    J Clin Invest; 1983 Apr 10; 71(4):816-31. PubMed ID: 6300188
    [Abstract] [Full Text] [Related]

  • 10. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
    de Man FH, de Beer F, van de Laarse A, Smelt AH, Leuven JA, Havekes LM.
    Atherosclerosis; 1998 Feb 10; 136(2):255-62. PubMed ID: 9543096
    [Abstract] [Full Text] [Related]

  • 11. Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation.
    Innerarity TL, Weisgraber KH, Arnold KS, Rall SC, Mahley RW.
    J Biol Chem; 1984 Jun 10; 259(11):7261-7. PubMed ID: 6327714
    [Abstract] [Full Text] [Related]

  • 12. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES, Tikkanen MJ, Cole TG, Davie JM, Schonfeld G.
    J Clin Invest; 1985 Feb 10; 75(2):361-9. PubMed ID: 3973009
    [Abstract] [Full Text] [Related]

  • 13. Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor.
    Koo C, Wernette-Hammond ME, Innerarity TL.
    J Biol Chem; 1986 Aug 25; 261(24):11194-201. PubMed ID: 3733751
    [Abstract] [Full Text] [Related]

  • 14. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
    Rall SC, Weisgraber KH, Innerarity TL, Mahley RW.
    Proc Natl Acad Sci U S A; 1982 Aug 25; 79(15):4696-700. PubMed ID: 6289314
    [Abstract] [Full Text] [Related]

  • 15. Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors.
    Mann WA, Meyer N, Berg D, Greten H, Beisiegel U.
    Atherosclerosis; 1999 Jul 25; 145(1):61-9. PubMed ID: 10428296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows.
    Schneider WJ, Kovanen PT, Brown MS, Goldstein JL, Utermann G, Weber W, Havel RJ, Kotite L, Kane JP, Innerarity TL, Mahley RW.
    J Clin Invest; 1981 Oct 25; 68(4):1075-85. PubMed ID: 6270194
    [Abstract] [Full Text] [Related]

  • 18. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS, Fazio S, Mahley RW.
    J Biol Chem; 1994 May 06; 269(18):13421-8. PubMed ID: 8175773
    [Abstract] [Full Text] [Related]

  • 19. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
    Evans AJ, Sawyez CG, Wolfe BM, Connelly PW, Maguire GF, Huff MW.
    J Lipid Res; 1993 May 06; 34(5):703-17. PubMed ID: 8509711
    [Abstract] [Full Text] [Related]

  • 20. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects.
    Milne RW, Weech PK, Blanchette L, Davignon J, Alaupovic P, Marcel YL.
    J Clin Invest; 1984 Mar 06; 73(3):816-23. PubMed ID: 6368590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.